The highly specific induction of RNA interference-mediated gene knockdown, based on the
direct application of small interfering RNAs (siRNAs), opens novel avenues towards …

We developed an immune‐related gene prognostic index (IGPI) associated with progression
and provided new insights into the tumour immune microenvironment (TIME) for prostate …

Genomic and transcriptomic data have been generated across a wide range of prostate
cancer (PCa) study cohorts. These data can be used to better characterize the molecular …

Long noncoding RNAs (lncRNAs) have evoked considerable interest in recent years due to
their critical functions in the regulation of disease processes. Abnormal expression of …

The delivery of small interfering RNAs (siRNA) is an efficient method for gene silencing
through the induction of RNA interference (RNAi). It critically relies, however, on efficient …

Background Prostate cancer (PCA) is the fifth leading cause of cancer-related deaths
worldwide, with limited treatment options in the advanced stages. The immunosuppressive …

In this study, we established a novel immunologic gene prognostic index (IGPI) to predict
metastasis and provided new insights into tumor immune microenvironment (TIME) for PCa …

Glioblastoma multiforme (GBM) is an extremely aggressive brain tumor, characterized by its
high genetic heterogeneity. In search of novel putative therapeutic RNA targets we …

Due to various unpleasant side effects and general ineffectiveness of current treatments for
prostate cancer (PCa), more and more people with PCa try to look for complementary and …

Androgen is beneficial for the prostate with normal functions but creates a risk for prostate
cancer progression. How androgen receptor (AR) mediates these various androgen actions …